RegenXBio's market cap is currently $487.46M. The company's EPS TTM is $-1.38; its P/E ratio is ―; RegenXBio is scheduled to report earnings on August 7, 2025, and the estimated EPS forecast is $-1.30. See an overview of income statement, balance sheet, and cash flow financials.
